Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$2.70
+3.45%
Mkt Cap $215.98M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+307.4%
Consensus $11.00 vs current $2.70
NASDAQ·Healthcare·Biotechnology
$2.70
+3.45%
Mkt Cap $215.98M
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+307.4%
Consensus $11.00 vs current $2.70